Minnesota Epilepsy Group — Saint Paul, Minnesota

Minnesota Epilepsy Group is a clinical research site located in Saint Paul, Minnesota, United States 55102-2383.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Minnesota Epilepsy Group has participated in 10 clinical trials with 2 currently active.

Therapeutic areas: Tuberous Sclerosis Complex (TSC), Lymphangioleiomyomatosis (LAM), Idiopathic Generalized Epilepsy.

Sponsors: Novartis Pharmaceuticals, NYU Langone Health, Lundbeck LLC.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Minnesota Epilepsy Group?

Minnesota Epilepsy Group has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Minnesota Epilepsy Group conducted?

Minnesota Epilepsy Group has 10 clinical trials on record, with 2 currently active. Their work covers Tuberous Sclerosis Complex (TSC), Lymphangioleiomyomatosis (LAM), Idiopathic Generalized Epilepsy.

Is Minnesota Epilepsy Group accredited by Crixeo Health?

Yes — Minnesota Epilepsy Group holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Minnesota Epilepsy Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.